A Preview Of Rigel Pharmaceuticals's Earnings

Rigel Pharmaceuticals RIGL is gearing up to announce its quarterly earnings on Tuesday, 2025-05-06. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Rigel Pharmaceuticals will report an earnings per share (EPS) of $0.09.

Investors in Rigel Pharmaceuticals are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Past Earnings Performance

The company's EPS beat by $0.25 in the last quarter, leading to a 8.11% drop in the share price on the following day.

Here's a look at Rigel Pharmaceuticals's past performance and the resulting price change:

Tracking Rigel Pharmaceuticals's Stock Performance

Shares of Rigel Pharmaceuticals were trading at $19.36 as of May 02. Over the last 52-week period, shares are up 60.59%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Rigel Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.